Gene mutation study aims to predict blood cancer risk in families

NCT ID NCT06022016

Recruiting now Knowledge-focused Sponsor: Institut Claudius Regaud Source: ClinicalTrials.gov ↗

First seen Jan 05, 2026 · Last updated May 13, 2026 · Updated 24 times

Summary

This study is for people with a DDX41 gene mutation that may increase the risk of blood diseases like leukemia. Researchers will follow up to 910 participants, including patients and their family members, to see how many develop blood problems over time. The goal is to create better guidelines for monitoring and counseling families with this genetic change.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Chu de Bordeaux
RECRUITING

Bordeaux, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Chu de Limoges
RECRUITING

Limoges, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Chu de Montpellier
RECRUITING

Montpellier, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
IUCT-O
RECRUITING

Toulouse, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Institut Paoli-Calmettes
RECRUITING

Marseille, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

DDX41 GENE MUTATION